Buy DLF; target of Rs 398: IndiaInfoline

Published on Mon, Nov 23, 2009 at 11:26 |  Source : CNBC-TV18

Updated at Mon, Nov 23, 2009 at 11:40  

121747 Investors following DLF. Share this News with them.
0
0
Share on Tumblr
Buy DLF; target of Rs 398: IndiaInfoline

ALSO READ

IndiaInfoline has recommended buy rating on DLF with a short term target of Rs 398, in its November 23, 2009 research report.

"DLF has seen impressive volume in Friday's trading session and appears to have taken support between Rs 350-355 zone. The bullish formation is confirmed after the stock gave a close above its 13-DMA with positive divergences in momentum oscillators. Volumes accompanying the breakout are encouraging, thereby adding confirmation to the bullish outlook. We recommend traders with high risk appetite to buy the stock in the range of Rs 372-378 for a short term target of Rs 398. A stop loss of Rs365 should be maintained on all long positions," says IndiaInfoline research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment.........

Attachments : IndiaInfoline_DLF.pdf

  

More on Moneycontrol

Trending News

Business News

Government to directly check BBM and other IM services
Competition ahoy: Monkey 1, Sensex in neck-and-neck race "Competition ahoy: Monkey 1, Sensex in neck-and-neck race"

From DJ Greek Fin Min Says Feb 17 Final Day For Greek Bond Exchange Offer

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 11 2012, 11:52 | Source: CNBC-TV18

TCS to expand centers in N.America; CY12 focus on Japan  

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com